Biosimilars: US FDA Favors Quality Range Testing For Comparative Analytical Assessments

 
• By Sue Sutter
  
Close Up of bunch of identical sharp graphite pencils. Studio shot. Concept of uniformity. Concept of similarity. - Image
New guidance reflects the US FDA's current thinking on statistical analyses methods for demonstrating biosimilarity. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics